What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the estimated listing price for Senores Pharmaceuticals Limited IPO?

Based on the upper price band of ₹391 and current GMP of ₹284, the estimated listing price is ₹675 (approx. 72.6% gain).

What is the expected profit per lot for Senores Pharmaceuticals Limited IPO?

With a lot size of 38 shares and current GMP of ₹284, expected profit per retail application lot is approximately ₹10,792.

IPO GreyPremiumLIVE

Grey Market Intelligence

Senores Pharmaceuticals Limited

ListedMainboard

Pharmaceuticals & Healthcare · NSE / BSE

Senores Pharmaceuticals Limited, incorporated on December 26, 2017, is an Ahmedabad-based pharmaceutical company focused on developing, manufacturing, and marketing high-quality branded generic medicines for both domestic and global markets. Its diversified product portfolio spans key therapeutic areas, including gastrointestinal, cardiovascular, respiratory, pain management, and anti-infective segments. Driven by strong R&D capabilities, the company emphasizes innovation, cost-effective product development, and strict regulatory compliance. Senores operates through a robust distribution network supported by subsidiaries such as Ratnatris Pharmaceuticals Private Limited and Havix Group, Inc. (Aavis Pharmaceuticals). It serves customers across major international markets, including the US, Europe, and other emerging regions.

Price Band

₹372 – ₹391

Issue Size

₹582 Cr

Lot Size

38 shares

GMP

₹284

+72.6%

Est. Listing

₹675

at current GMP

Subscribed

97.25x

overall

Open

20 Dec 2024

24 Dec 2024

Allotment

26 Dec 2024

Refund

27 Dec 2024

Demat Credit

28 Dec 2024

Listing

30 Dec 2024

Last updated 12 days ago

Overview Live GMP Live Subscription Allotment Status

Live Grey Market Premium

Senores Pharmaceuticals Limited GMP Today

Last updated: 19 Oct 2026

Current Premium

₹284+72.6%

Issue Price (Upper)

₹391

Band: ₹372 – ₹391

Estimated Listing Price

₹675

Upper price + GMP

Lot Size

38 shares

Min investment ₹14,858

Date	GMP (₹)	GMP %	Est. Listing
31 Oct 2026	+₹284	72.6%	₹675
30 Oct 2026	+₹284	72.6%	₹675
29 Oct 2026	+₹256	65.4%	₹647

About Senores Pharmaceuticals Limited Public Issue & Market Profile

Senores Pharmaceuticals Limited is bringing an initial public offering (IPO) in the Pharmaceuticals & Healthcare sector with an aggregate issue size of ₹582.11 Crores. The shares are offered at a price band of ₹372 to ₹391 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.

Public Issue & Pricing Context:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Basis of Allotment & Listing Timeline:

Following the close of bidding on 2024-12-24, the basis of allotment is scheduled to be finalized on 2024-12-26. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.

Frequently Asked Questions

What is Senores Pharmaceuticals Limited IPO GMP today?

The latest grey market premium for Senores Pharmaceuticals Limited IPO is ₹284, which indicates an expected listing price of ₹675.

What does Kostak Rate and Sauda mean in IPO GMP?

Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.

Is Grey Market Premium officially recognized?

No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.